Optimization of amide-based EP3 receptor antagonists
- PMID: 27107947
- DOI: 10.1016/j.bmcl.2016.04.009
Optimization of amide-based EP3 receptor antagonists
Abstract
Prostaglandin E receptor subtype 3 (EP3) antagonism may treat a variety of symptoms from inflammation to cardiovascular and metabolic diseases. Previously, most EP3 antagonists were large acidic ligands that mimic the substrate, prostaglandin E2 (PGE2). This manuscript describes the optimization of a neutral small molecule amide series with improved lipophilic efficiency (LipE) also known as lipophilic ligand efficiency (LLE) ((a) Nat. Rev. Drug Disc.2007, 6, 881; (b) Annu. Rep. Med. Chem.2010, 45, 380).
Keywords: EP3 receptor; GPCR; Indazole; LipE; Metabolites; P-gp; PGE2.
Copyright © 2016 Elsevier Ltd. All rights reserved.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Chemical Information
